For instance, idelalisib induces apoptosis in chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL) by destabilizing Mcl-1 and Bcl-xL, highlighting its pro-death efficacy in hematologic malignancies. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.